Progressive Corporation
PGR
$213.48
-1.30%
Progressive Corporation is a leading U.S. property and casualty insurer that underwrites private and commercial auto insurance and specialty lines, with nearly 27 million personal auto policies in force and distribution split between independent agents and direct-to-consumer channels. As one of the largest auto insurers in the United States, Progressive is distinguished by its data-driven underwriting model, telematics capabilities, and a direct-channel strategy that has consistently allowed it to take market share from peers. The current investor narrative centers on the durability of its underwriting profitability and the earnings power of its roughly $94 billion investment float, which stands to benefit from elevated interest rates and rising investment income. At the same time, debate has intensified around decelerating premium growth, a high but unreliable dividend yield, and a recent JP Morgan downgrade to Neutral, which has tempered the previously bullish sentiment on the stock.…
PGR
Progressive Corporation
$213.48
Related headlines
Investment Opinion: Should I buy PGR Today?
The synthesized recommendation is Hold. Progressive's core thesis is that its industry-leading underwriting profitability and massive investment float provide a durable earnings base, but decelerating growth and margin volatility limit near-term upside. The analyst consensus rating of 'hold' (mean 2.64) and average target price of $231.71 (8.5% upside) align with this balanced view, suggesting the stock is fairly valued with modest upside potential.
Supporting evidence for the Hold rating includes: (1) valuation at 11.81x trailing PE, a discount to the 14-18x sector average, but justified by slower growth; (2) revenue growth of 7.37% YoY, down from double-digit rates, indicating maturation; (3) net margin of 14.02% in Q2 2026, up from 12.71% in Q1 2026, showing profitability resilience; (4) TTM free cash flow of $16.42 billion, providing ample capital flexibility; and (5) ROE of 37.29%, far exceeding the sector average of ~12%, which supports a premium P/B of 4.40x. The implied upside to the average target is modest, and the high target of $309 (44.7% upside) is offset by the low target of $198 (7.3% downside), reflecting wide analyst disagreement.
The biggest risks that could invalidate the Hold thesis are: (1) a continued decline in gross margin, which fell to 25.15% in Q2 2026 from 37.66% in Q1 2026, potentially signaling underwriting deterioration; (2) further deceleration in premium growth below 5%, which would pressure earnings; and (3) a broader market rotation away from defensive stocks, given PGR's low beta of 0.259. The rating would upgrade to Buy if the PE compresses below 10x while earnings remain stable, or if revenue growth reaccelerates above 10%. It would downgrade to Sell if gross margin falls below 20% or if net income declines year-over-year for two consecutive quarters. Relative to its own history and peers, PGR appears undervalued on a PE basis but fairly valued when considering growth deceleration and margin risks.
Sign up to view all
PGR 12-Month Price Forecast
Progressive presents a balanced risk/reward profile with a neutral stance. The company's superior profitability and discounted valuation are offset by decelerating growth and margin volatility. The stock's low beta (0.259) makes it a defensive holding, but relative underperformance (-26.80% vs. SPY over 1 year) suggests limited near-term catalysts. I would upgrade to bullish if Q3 2026 earnings show gross margin recovery above 30% and revenue growth reaccelerates above 10%. I would downgrade to bearish if gross margin falls below 20% or if net income declines year-over-year for two consecutive quarters.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Progressive Corporation's 12-month outlook, with a consensus price target around $231.38 and implied upside of +8.4% versus the current price.
Average Target
$231.38
0 analysts
Implied Upside
+8.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$198 - $302
Analyst target range
Progressive is covered by 21 analysts, with a consensus recommendation of "hold" and a recommendation mean of 2.64 on a scale where 1 is Strong Buy and 5 is Strong Sell. The average target price of $231.71 implies approximately 8.5% upside from the current price of $213.48, suggesting a modestly constructive but not overwhelmingly bullish outlook. The consensus leans neutral, reflecting the tension between the company's strong fundamentals and concerns about growth deceleration and potential margin normalization. The target price range spans from a low of $198.00 to a high of $309.00, representing a spread of $111 or roughly 56% of the average target, which signals meaningful disagreement among analysts about the company's trajectory. The high target of $309.00 likely assumes continued underwriting outperformance, accelerating investment income from the $94 billion float, and multiple expansion back toward historical averages, while the low target of $198.00 prices in margin compression, competitive pressures, or a broader economic slowdown that could impact premium growth. Recent institutional ratings show a predominantly neutral stance, with JP Morgan downgrading from Overweight to Neutral on July 14, 2026, and most other firms maintaining Hold or Market Perform ratings. The estimated EPS average of $15.98 for the forward period, with a range of $14.81 to $17.18, provides a fundamental anchor for these targets, and the wide EPS range further underscores the uncertainty around future profitability. The lack of recent upgrades and the presence of a notable downgrade suggest that analyst sentiment has cooled, which could limit near-term upside until the company demonstrates reaccelerating growth or margin stability.
Bulls vs Bears: PGR Investment Factors
The bull case rests on Progressive's exceptional profitability (ROE 37.29%), deep valuation discount (PE 11.81x vs. peers 14-18x), and massive free cash flow ($16.42 billion TTM), which provide a strong margin of safety. However, the bear case is gaining traction due to decelerating revenue growth (7.37% YoY), margin volatility (gross margin fell to 25.15% in Q2 2026), and a JP Morgan downgrade that reflects cooling analyst sentiment. Currently, the bear evidence appears slightly stronger because the market is pricing in peak-cycle underwriting margins and growth normalization, as evidenced by the forward PE (13.11x) exceeding the trailing PE (11.81x) and the stock's 26.80% underperformance versus SPY over the past year. The single most important tension is whether Progressive can sustain its underwriting profitability and investment income growth in a decelerating premium environment; if margins stabilize and investment income accelerates, the stock could re-rate upward, but if margin compression continues, the valuation discount may persist or widen.
Bullish
- Exceptional ROE of 37.29%: Progressive's return on equity of 37.29% is more than triple the typical P&C insurance sector average of 10-15%, reflecting a durable underwriting moat and superior capital efficiency. This level of profitability supports continued book value compounding even if premium growth moderates.
- Deep valuation discount to peers: The trailing PE of 11.81x sits well below the 14-18x range typical for large-cap P&C insurers, implying a 15-35% discount. The PEG ratio of 0.352 further suggests the market is undervaluing earnings growth relative to history.
- Robust free cash flow generation: TTM free cash flow of $16.42 billion comfortably covers the $7.97 billion in dividends paid in Q1 2026, with a payout ratio of just 25.39%. This provides ample flexibility for buybacks, growth investments, or dividend increases without external financing.
- Rising investment income from $94B float: Progressive's $94 billion investment float stands to benefit from elevated interest rates, boosting investment income and earnings. Recent news highlights this as a key earnings driver beyond underwriting, adding a second growth engine.
Bearish
- Decelerating revenue growth: Q2 2026 revenue grew 7.37% year-over-year to $23.62 billion, a sharp slowdown from prior double-digit rates. This deceleration raises concerns about the sustainability of premium growth as the auto insurance market matures.
- Margin volatility and compression risk: Gross margin fell to 25.15% in Q2 2026 from 37.66% in Q1 2026 and 29.28% in Q4 2025, highlighting quarter-to-quarter volatility. If underwriting margins normalize toward historical averages, earnings could face downward pressure.
- Analyst downgrade and neutral consensus: JP Morgan downgraded PGR from Overweight to Neutral on July 14, 2026, and the consensus recommendation is 'hold' with a mean of 2.64. The average target price of $231.71 implies only 8.5% upside, limiting near-term appeal.
- Persistent relative underperformance: PGR has underperformed SPY by 26.80% over 1 year and 13.81% over 6 months, with a 1-year price decline of 11.79%. This weak relative strength suggests institutional rotation away from the stock despite strong fundamentals.
PGR Technical Analysis
Progressive is in a recovery phase within a broader range-bound consolidation, with the current price of $213.48 sitting at approximately 41.2% of its 52-week range between a low of $189.20 and a high of $248.17. The 1-year price change of -11.79% reflects a meaningful pullback from prior highs, though the stock has stabilized well above its 52-week low, suggesting the worst of the selling pressure has passed. This positioning implies the stock is neither overextended nor deeply discounted, but rather in a neutral zone where direction will be determined by the next catalyst. Recent momentum is modestly positive, with a 3-month gain of 4.20% and a 6-month gain of 3.63%, but the 1-month change of -1.74% shows a slight deceleration that diverges from the medium-term uptrend. Relative strength versus SPY is negative across most timeframes, including -26.80% over 1 year and -13.81% over 6 months, indicating persistent underperformance, though the 3-month relative strength of +2.20% suggests a nascent stabilization. Key technical support lies near the 52-week low of $189.20, while resistance is established at the 52-week high of $248.17; a breakout above resistance would signal renewed institutional confidence, whereas a breakdown below support could trigger momentum-driven selling. The beta of 0.259 is remarkably low, meaning the stock is roughly 74% less volatile than the broader market, which supports defensive positioning but also limits upside participation in strong market rallies.
Beta
0.26
0.26x market volatility
Max Drawdown
-24.6%
Largest decline past year
52-Week Range
$189-$248
Price range past year
Annual Return
-11.8%
Cumulative gain past year
| Period | PGR Return | S&P 500 |
|---|---|---|
| 1m | -1.7% | -0.5% |
| 3m | +4.2% | +2.3% |
| 6m | +3.6% | +16.6% |
| 1y | -11.8% | +14.8% |
| ytd | +0.6% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PGR Fundamental Analysis
Progressive's revenue trajectory remains solidly positive, with Q2 2026 revenue of $23.62 billion representing 7.37% year-over-year growth from $21.99 billion in Q2 2025. The multi-quarter trend shows consistent sequential expansion, from $22.18 billion in Q1 2026 and $22.74 billion in Q4 2025, with the Personal Lines segment generating $18.66 billion and Commercial Lines contributing $2.60 billion. While growth is decelerating from the double-digit pace seen in prior years, the absolute revenue base continues to expand, and the company's ability to grow premiums while maintaining underwriting discipline supports a constructive long-term investment case. Profitability remains robust, with Q2 2026 net income of $3.31 billion and a net margin of 14.02%, up from 12.71% in Q1 2026 and 11.62% in Q3 2025. Gross margin stood at 25.15% in Q2 2026, though this was lower than the 37.66% reported in Q1 2026 and 29.28% in Q4 2025, reflecting some quarter-to-quarter volatility in underwriting results. The operating margin of 16.23% and ROE of 37.29% are exceptionally strong for the insurance industry, where ROEs typically range from 10% to 15%, underscoring Progressive's superior underwriting and capital efficiency. The balance sheet is conservatively managed, with a debt-to-equity ratio of just 0.227 and a current ratio of 0.586, the latter reflecting the insurance business model where policy liabilities are classified as current. Free cash flow on a trailing twelve-month basis is a robust $16.42 billion, easily covering the $7.97 billion in dividends paid in Q1 2026, and the company's ROA of 7.84% demonstrates efficient asset utilization. With a payout ratio of 25.39% and a dividend yield of 2.15%, Progressive generates more than enough internal cash to fund growth, support its dividend, and maintain financial flexibility without reliance on external financing.
Quarterly Revenue
$23.6B
2026-06
Revenue YoY Growth
+7.4%
YoY Comparison
Gross Margin
25.1%
Latest Quarter
Free Cash Flow
$16.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PGR Overvalued?
Because Progressive is solidly profitable with positive net income of $3.31 billion in Q2 2026, the PE ratio is the appropriate primary valuation metric. The trailing PE of 11.81x and forward PE of 13.11x are both low on an absolute basis, but the forward multiple being higher than the trailing suggests the market expects some earnings normalization or moderation ahead, rather than acceleration. The PEG ratio of 0.352 is notably below 1.0, which traditionally signals undervaluation relative to expected growth, though this metric can be distorted for insurers with cyclical earnings. On a peer comparison basis, Progressive's trailing PE of 11.81x is well below the broader Financial Services sector average, which typically ranges from 14x to 18x for large-cap P&C insurers, implying a discount of roughly 15% to 35%. The price-to-book ratio of 4.40x and price-to-sales ratio of 1.52x further contextualize the valuation, with the P/B multiple reflecting the market's premium for Progressive's industry-leading ROE of 37.29% versus a sector average closer to 12%. The EV/EBITDA of 9.47x is also modest, suggesting the market is not pricing in aggressive growth expectations despite the company's strong competitive position. Historically, Progressive's PE ratio has ranged from a low of approximately 10.3x in Q1 2026 to a high of 58.1x in Q2 2023, with the current 11.81x sitting near the bottom of that multi-year band. The PS ratio of 1.52x is similarly near historical lows compared to the 5.2x to 8.1x range seen throughout 2024 and 2025, indicating a significant compression in valuation multiples. This compression could represent a value opportunity if earnings remain resilient, or it could signal that the market is pricing in peak-cycle underwriting margins and expecting deterioration ahead.
PE
11.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 10x~58x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.5x
Enterprise Value Multiple
Investment Risk Disclosure
Progressive's financial risks are relatively contained but not negligible. The debt-to-equity ratio of 0.227 is conservative, yet the current ratio of 0.586 reflects the insurance business model where policy liabilities are current; this is normal but leaves little short-term liquidity buffer if claims surge unexpectedly. More importantly, the gross margin volatility is striking: it fell to 25.15% in Q2 2026 from 37.66% in Q1 2026, a 12.5 percentage point swing in a single quarter, indicating that underwriting results can deteriorate rapidly due to catastrophe losses or adverse reserve development. Additionally, revenue growth has decelerated to 7.37% YoY, and if this slows further, the company's ability to absorb fixed costs could pressure operating margins, which already declined from 17.82% in Q1 2026 to 16.23% in Q2 2026.
Market and competitive risks are significant given Progressive's premium valuation relative to its own history and the sector. The stock trades at a trailing PE of 11.81x, which is near the low end of its historical range (10.3x to 58.1x), but the forward PE of 13.11x is higher than the trailing, suggesting the market expects earnings normalization. If earnings decline, the stock could face multiple compression. The beta of 0.259 indicates low correlation with the broader market, which is defensive but also means PGR may lag in strong bull markets. Competitive pressures in auto insurance are intense, with peers like GEICO and Allstate aggressively competing on price and technology. The recent JP Morgan downgrade to Neutral on July 14, 2026, highlights growing concerns about growth sustainability and margin pressure, which could trigger further analyst downgrades if Q3 results disappoint.
The worst-case scenario for Progressive would involve a combination of accelerating claims inflation, a sharp increase in catastrophe losses, and a slowdown in premium growth, leading to a significant earnings miss and multiple compression. In this scenario, the stock could retest its 52-week low of $189.20, representing a decline of approximately 11.4% from the current price of $213.48. If analyst bear-case targets are met, the low target of $198.00 implies a 7.3% downside, but a more severe outcome could see the stock fall to the $180-$190 range if underwriting margins turn negative. The maximum drawdown over the past year was -24.65%, and a similar drawdown from the current price would put the stock near $160, a 25% loss. Investors should be prepared for a potential 10-25% downside in a severe adverse scenario, with the 52-week low of $189.20 serving as a key psychological support level.
FAQ
The key risks for PGR, ranked by severity, are: (1) Underwriting margin compression—gross margin fell to 25.15% in Q2 2026 from 37.66% in Q1 2026, and further deterioration could significantly reduce earnings; (2) Growth deceleration—revenue growth slowed to 7.37% YoY, and a continued slowdown could pressure the valuation multiple; (3) Competitive pressures—intense competition in auto insurance from GEICO and Allstate could lead to market share losses and pricing pressure; (4) Macro sensitivity—although beta is low at 0.259, a broad economic downturn could reduce premium growth and increase claims. Additionally, the JP Morgan downgrade to Neutral on July 14, 2026, signals cooling analyst sentiment, which could trigger further downgrades if results disappoint.
The 12-month forecast for PGR includes three scenarios: bull case (25% probability) with a target range of $248-$309, driven by margin stabilization and investment income growth; base case (55% probability) with a target range of $220-$240, assuming stable underwriting and mid-single-digit revenue growth; and bear case (20% probability) with a target range of $189-$198, reflecting margin compression and growth slowdown. The base case is most likely, anchored by the analyst average target of $231.71 and a consensus Hold rating. The key assumption behind the base case is that net margin stabilizes around 13-14% and revenue grows 5-8% YoY, with no major catastrophe losses.
PGR appears undervalued on a relative basis. Its trailing PE of 11.81x is below the 14-18x range for large-cap P&C insurers, and its PEG ratio of 0.352 suggests the market is not fully pricing in earnings growth. The price-to-book ratio of 4.40x is a premium to the sector, but justified by an ROE of 37.29% versus the sector average of ~12%. Compared to its own history, the PE is near the low end of its multi-year range (10.3x to 58.1x), and the PS ratio of 1.52x is well below the 5.2x-8.1x seen in 2024-2025. The market appears to be pricing in peak-cycle underwriting margins and growth deceleration, implying that if earnings remain resilient, the stock could re-rate higher.
PGR is a good buy for value-oriented investors seeking exposure to a high-quality insurer with a durable competitive advantage. The stock trades at a trailing PE of 11.81x, a discount to the sector average of 14-18x, and offers an 8.5% upside to the analyst average target of $231.71. However, the risk/reward is balanced by decelerating revenue growth (7.37% YoY) and margin volatility, with gross margin falling to 25.15% in Q2 2026. The biggest downside risk is a retest of the 52-week low of $189.20, representing an 11.4% decline. For long-term investors comfortable with moderate volatility (beta 0.259), PGR is a solid buy on dips, but near-term upside may be limited until growth reaccelerates.
PGR is more suitable for long-term investment due to its low beta (0.259), stable dividend (yield 2.15%), and strong fundamentals (ROE 37.29%, TTM FCF $16.42 billion). The stock's earnings visibility is high, but near-term growth deceleration and margin volatility make it less attractive for short-term trading. A minimum holding period of 2-3 years is recommended to ride out underwriting cycles and benefit from compounding book value. Short-term traders may find opportunities around quarterly earnings, but the low volatility limits large price swings. Income investors should note the dividend is not guaranteed and can vary with special dividends, so it's not a pure income play.